069620.KS
069620.KS
KR7069620003
DAEWOONG PHARM
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.25T EUR
1.36T EUR
1.96T EUR
1.98T EUR
Enterprise Value
2.14T EUR
2.13T EUR
2.7T EUR
2.64T EUR
Valuation Multiples
Trailing P/E
--
6.96x
9.82x
11.4x
Forward P/E
--
--
--
--
Price to Sales
0.76x
0.83x
1.23x
1.63x
Price to Book
--
1.28x
1.91x
1.97x
EV/Revenue
1.31x
1.3x
1.69x
2.18x
EV/EBITDA
8.34x
6.98x
9.56x
10.5x
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-14%
-12.75%
-7.27%
-3.28%
ende